Vaccine equity: Past, present, and future

Rieke van der Graaf; Joyce L. Browne; Amrish Y. Baidjoe

doi:10.1016/j.xcrm.2022.100551

Vaccine equity: Past, present, and future

Rieke van der Graaf
, Joyce L. Browne
, Amrish Y. Baidjoe^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

14 Downloads (Pure)

Abstract

The term “vaccine equity” primarily points to the enormous imbalance in global COVID-19 vaccine distribution. Vaccine equity should adopt a normative approach toward “health equity,” and various stakeholders across the vaccine life cycle must practice it. The momentum gathered during this pandemic must be used to correct these structural imbalances.

Original language	English
Article number	100551
Pages (from-to)	1-4
Journal	Cell reports medicine
Volume	3
Issue number	3
DOIs	https://doi.org/10.1016/j.xcrm.2022.100551
Publication status	Published - 15 Mar 2022

Keywords

COVID-19 Vaccines/therapeutic use
COVID-19/epidemiology
Health Equity
Humans
Pandemics/prevention & control
Vaccines/therapeutic use

Access to Document

10.1016/j.xcrm.2022.100551Licence: CC BY-NC-ND

1-s2.0-S266637912200057X-mainFinal published version, 789 KBLicence: CC BY-NC-ND

Cite this

@article{376a6b88144242b8965b54376fae6936,

title = "Vaccine equity: Past, present, and future",

abstract = "The term “vaccine equity” primarily points to the enormous imbalance in global COVID-19 vaccine distribution. Vaccine equity should adopt a normative approach toward “health equity,” and various stakeholders across the vaccine life cycle must practice it. The momentum gathered during this pandemic must be used to correct these structural imbalances.",

keywords = "COVID-19 Vaccines/therapeutic use, COVID-19/epidemiology, Health Equity, Humans, Pandemics/prevention \& control, Vaccines/therapeutic use",

author = "\{van der Graaf\}, Rieke and Browne, \{Joyce L.\} and Baidjoe, \{Amrish Y.\}",

note = "Funding Information: The authors would like to express their appreciation to the suggestions of Dr. Judith van de Kamp about the historical context on health inequities and would like to thank all global actors who continue to tirelessly address matters of unequal access to health both in speech as well in practice. Conceptualization, R.v.d.G. J.L.B. A.Y.B.; Writing – original draft, R.v.d.G.; Writing – original figure, J.L.B.; Writing – Review \& Editing, R.v.d.G. J.L.B. and A.Y.B. R.v.d.G. J.L.B. and A.Y.B. declare no competing interests. Publisher Copyright: {\textcopyright} 2022 The Author(s)",

year = "2022",

month = mar,

day = "15",

doi = "10.1016/j.xcrm.2022.100551",

language = "English",

volume = "3",

pages = "1--4",

journal = "Cell reports medicine",

issn = "2666-3791",

publisher = "Cell Press",

number = "3",

}

TY - JOUR

T1 - Vaccine equity

T2 - Past, present, and future

AU - van der Graaf, Rieke

AU - Browne, Joyce L.

AU - Baidjoe, Amrish Y.

N1 - Funding Information: The authors would like to express their appreciation to the suggestions of Dr. Judith van de Kamp about the historical context on health inequities and would like to thank all global actors who continue to tirelessly address matters of unequal access to health both in speech as well in practice. Conceptualization, R.v.d.G. J.L.B. A.Y.B.; Writing – original draft, R.v.d.G.; Writing – original figure, J.L.B.; Writing – Review & Editing, R.v.d.G. J.L.B. and A.Y.B. R.v.d.G. J.L.B. and A.Y.B. declare no competing interests. Publisher Copyright: © 2022 The Author(s)

PY - 2022/3/15

Y1 - 2022/3/15

N2 - The term “vaccine equity” primarily points to the enormous imbalance in global COVID-19 vaccine distribution. Vaccine equity should adopt a normative approach toward “health equity,” and various stakeholders across the vaccine life cycle must practice it. The momentum gathered during this pandemic must be used to correct these structural imbalances.

AB - The term “vaccine equity” primarily points to the enormous imbalance in global COVID-19 vaccine distribution. Vaccine equity should adopt a normative approach toward “health equity,” and various stakeholders across the vaccine life cycle must practice it. The momentum gathered during this pandemic must be used to correct these structural imbalances.

KW - COVID-19 Vaccines/therapeutic use

KW - COVID-19/epidemiology

KW - Health Equity

KW - Humans

KW - Pandemics/prevention & control

KW - Vaccines/therapeutic use

UR - https://www.scopus.com/pages/publications/85126298530

U2 - 10.1016/j.xcrm.2022.100551

DO - 10.1016/j.xcrm.2022.100551

M3 - Article

C2 - 35474741

AN - SCOPUS:85126298530

SN - 2666-3791

VL - 3

SP - 1

EP - 4

JO - Cell reports medicine

JF - Cell reports medicine

IS - 3

M1 - 100551

ER -

Vaccine equity: Past, present, and future

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this